NuScriptRX has raised $8m of funding from a range of venture capital firms, several of which operate under the local TNInvestco program.

Last month, DST Global, the fund run by Russian businessman Yuri Milner, invested $50m in ZocDoc.

The biopharmaceutical company has extended its series C round with funds from investors including Roche.

In February last year, NABsys raised $7m in its B round, following $4m at launch in 2009, and Stata said: "NABsys represents the merger of two industries which, until now, have been quite disparate: semiconductors and genomics.

Buyout firm Welsh Carson takes control of the diabetes treatment company as part of the C round.

The consumer loyalty company, which is backed by energy company ITC Holdings, has entered into a strategic alliance with the multinational Aeroplan, while securing a further round of funding.